Who owns BOLT BIOTHERAPEUTICS INC?
- Ticker: BOLT
- CUSIP Number: 097702104
Tip: Access positions for across all investors
Analyze quarterly positions in Bolt Biotherapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Bolt Biotherapeutics stock
Who bought or sold BOLT BIOTHERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vivo Capital | 3.5M | $4.9M | 0% | Mar 2024 |
|
| Tang Capital Management | 3.4M | $4.8M | -6% | Mar 2024 |
|
| Sofinnova Ventures | 2.8M | $3.9M | 0% | Mar 2024 |
|
| Citadel Advisors | 2.4M | $3.4M | -2% | Mar 2024 |
|
| Newtyn Management | 1.7M | $2.4M | 9% | Mar 2024 |
|
| OrbiMed Advisors | 1.5M | $2.2M | 0% | Mar 2024 |
|
| Samsara BioCapital | 1.0M | $1.5M | 0% | Mar 2024 |
|
| Vanguard Group | 1.0M | $1.5M | 11% | Mar 2024 |
|
| Board of Trustees of The Leland Stanford Junior University | 720k | $1.0M | 0% | Mar 2024 |
|
| Acuitas Investments | 518k | $725k | 13% | Mar 2024 |
|
| Adage Capital Partners GP | 500k | $700k | 0% | Mar 2024 |
|
| Geode Capital Management | 348k | $487k | -4% | Mar 2024 |
|
| BlackRock | 255k | $357k | -1% | Mar 2024 |
|
| Bridgeway Capital Management | 111k | $156k | 0% | Mar 2024 |
|
| Marquette Asset Management | 97k | $135k | 0% | Mar 2024 |
|
| FMR | 79k | $111k | 0% | Mar 2024 |
|
| Squarepoint Ops | 78k | $109k | -2% | Mar 2024 |
|
| Millennium Management | 46k | $64k | -2% | Mar 2024 |
|
| Northern Trust | 41k | $57k | 32% | Mar 2024 |
|
| Morgan Stanley | 25k | $25k | -85% | Mar 2024 |
|
| Two Sigma Securities | 24k | $33k | -63% | Mar 2024 |
|
| Advisor Group Holdings | 15k | $21k | 277% | Mar 2024 |
|
| XTX Topco | 13k | $18k | 100% | Mar 2024 |
|
| UBS Group | 12k | $17k | 59% | Mar 2024 |
|
| Virtu Financial | 11k | $15k | 100% | Mar 2024 |
|
| Tower Research Capital | 5.5k | $7.8k | 100% | Mar 2024 |
|
| ADAR1 Capital Management | 5.0k | $7.0k | 100% | Mar 2024 |
|
| Jpmorgan Chase & Co | 840.00 | $1.2k | 0% | Mar 2024 |
|
| Bank of America Corporation | 628.00 | $879.011600 | 0% | Mar 2024 |
|
| Wells Fargo & Company | 211.00 | $294.999100 | 2% | Mar 2024 |
|
| Barclays | 139.00 | $0 | 0% | Mar 2024 |
|
| Salem Investment Counselors | 40.00 | $56.000000 | 0% | Mar 2024 |
|
| Qube Research & Technologies | 2.00 | $3.000000 | 0% | Mar 2024 |
|
| Royal Bank of Canada | 1.00 | $0 | -100% | Mar 2024 |
|
Who sold out of Bolt Biotherapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Privium Fund Management | Sep 2023 | 117k | $121k |
| Jane Street | Dec 2023 | 56k | $63k |
| Citigroup | Dec 2023 | 2.3k | $2.6k |
| Federated Investors | Sep 2023 | 1.2k | $1.2k |